In the News | Friends of Cancer Research

You are here

In the News

May 19, 2020
The FDA said Tuesday it’s pairing up with the data company Aetion to research Covid-19 complications and what types of medicines virus patients are taking, which could help researchers learn more... Read more
May 14, 2020
Michelle McMurry-Heath doesn’t talk about biotech the way her peers do.   Where other executives and experts might bring up “access,” and “reimbursement,” McMurry-Heath talks about fairness and... Read more
May 8, 2020
Responding to COVID-19 is forcing regulators, medical product developers and health systems to get real about real-world data and evidence as they reach for every available tool to learn about the... Read more
May 8, 2020
Senators Edward J. Markey (D-MA) and Thom Tillis (R-NC) and 31 of their Senate colleagues are calling for protections for the U.S. scientific research community during the coronavirus pandemic.  ... Read more
April 30, 2020
Investigators from the non-profit Friends of Cancer Research (FOCR)'s tumor mutational burden (TMB) harmonization project shared new data this week from their second phase in which they continue to... Read more
April 30, 2020
Life won’t completely return to normal while the novel coronavirus remains a threat to health and to life. More than 60,000 Americans have already lost their lives to this virus; while older people... Read more
April 28, 2020
Today, Friends of Cancer Research (Friends) released the findings from Phase 2 of its TMB Harmonization Project at the AACR Virtual Annual Meeting I. These results are the outcome of the large-scale... Read more
April 28, 2020
Patients with cancer and those who have recently completed treatment are finding it challenging to get necessary health care in the midst of the COVID-19 pandemic, and many are experiencing financial... Read more
April 25, 2020
Can patients with cancer and preexisting autoimmune disorders safely benefit from immunotherapy? The answer has been unclear, with only retrospective studies and anecdotal reports guiding oncologists... Read more
April 21, 2020
Executive Summary Agency is going outside its ‘comfort zone’ to leverage different streams of existing real-world data sources to quickly assess the impact of potential treatment approaches, Amy... Read more